Publications and Products
The Economics of Diabetes Mellitus:
An Annotated Bibliography
The numbers
in this index refer to abstract numbers rather than to page numbers.
Index
of Titles
A
B C D E
F G H I
L M N O
P Q R S
T U V W
A
Access to
Coverage: Health Insurance for People With Diabetes. 253
ACE Inhibition
in Diabetic Patients: Economic Implications. 158
Adherence
to Treatment and Social Support in Patients with Non-Insulin Dependent
Diabetes. 13
Ambulatory
Medical Care for Diabetes. 254
Ambulatory
Nutrition Care: Adults-Diabetes Mellitus. 255
American
Diabetes Association Annual Meeting 1996: Managed Care and Change in Medicine.
227
Amputation
in the Diabetic Population: Incidence, Causes, Cost, Treatment, and Prevention.
256
Amputations
in the Surgical Budget. 139
Amputations
in the Surgical Budget (letter). 140
Analysis
of Direct Cost of Standard Compared with Intensive Insulin Treatment of
Insulin-Dependent Diabetes Mellitus and Cost of Complications. 14
Applying
Recent Findings to Clinical Care in Type II Diabetes. 257
Assessing
the Costs and Benefits of Medical Research: The Retinopathy Study. 258
Assessment
of the Effect of a Comprehensive Diabetes Management Program on Hospital
Admission Rates of Children with Diabetes Mellitus. 15
Audit in
General Practice by a Receptionist: A Feasibility Study. 16
B
Bedside Blood
Sugar Determinations in the Critically Ill. 17
Benefits
of Prevention: The Medicare Therapeutic Shoe Demonstration. 107
Budget Trends
and Issues Affecting Biomedical Research: A Perspective From the National
Institute of Diabetes and Digestive and Kidney Diseases. 229
The Burden
of Diabetes in North Carolina. 192
The Burden
of Diabetes: The Cost of Diabetes Hospitalizations in Wisconsin, 1994.
141
C
Capillary
Blood Glucose Screening for Gestational Diabetes: A Preliminary Investigation.
120
Capillary
Glucose Determination in the Screening of Gestational Diabetes. 121
Cardiovascular
Complications of Diabetes Mellitus: What We Know and What We Need to Know
About Their Prevention. 259
Cardiovascular
Morbidity and Mortality in Type 2 Diabetic Patients: A 22-Year Historical
Cohort Study in Dutch General Practice. 18
Care of the
Diabetic Child in the Community. 19
Case Management
and Quality of Care for Diabetic Patients. 260
CDC Diabetes
Control Programs — Overview of Diabetes Patient Education. 230
The Charges
for ESRD Treatment of Diabetics. 176
Clinical
Economics: A Guide to the Economic Analysis of Clinical Practices. 261
Clinical
Experience with a Screening Program for Gestational Diabetes. 122
Clinical
Features and Health-Care Costs of Diabetic Nephropathy. 142
A Clinician's
Guide to Cost-Effective Analysis. 262
Closing the
Gap: The Problem of Diabetes Mellitus in the United States. 159
A Comparison
of Accuracy and Estimated Cost of Methods for Home Blood Glucose Monitoring.
20
Comparison
of Different Models of Diabetes Care on Compliance with Self-Monitoring
of Blood Glucose by Memory Glucometer. 21
Comparison
of Five Glucose Meters for Self-Monitoring of Blood Glucose by Diabetic
Patients. 52
Comparison
of Glycosylated Hemoglobin and Fasting Plasma Glucose with Two-Hour Post-Load
Plasma Glucose in the Detection of Diabetes Mellitus. 3
Comparison
of Screening Tests for Non-Insulin-Dependent Diabetes Mellitus. 4
Conference
Report: Approaches to the Treatment of Type II Diabetes and Developments
in Glucose Monitoring and Insulin Administration. 53
Continuous
Quality Improvement Can Improve Glycemic Control for HMO Patients with
Diabetes. 22
Conversion
from Glipizide to Glyburide: A Prospective Cost-Impact Survey. 168
Cost Analysis
of Kidney-Pancreas and Kidney-Islet Transplant. 92
Cost-Benefit
Analysis of Diabetic Eye Disease. 66
Cost-Benefit
Analysis of Preconception Care for Women with Established Diabetes Mellitus.
134
Cost-Benefit
Analysis of Preconception Care for Women with Established Diabetes Mellitus.
Final Report. 135
A Cost-Benefit
Analysis of Subcutaneous Insulin Pump Infusion Therapy for Insulin-Dependent
Diabetes Mellitus. 23
Cost Concepts
for Diabetes Educators: An Introduction. 263
Cost-Effective
Approach to Office Screening for Gestational Diabetes. 125
Cost-Effective
Criteria for Glucose Screening. 126
Cost-Effective
Screening for Retinopathy Using a Nonmydriatic Retinal Camera in a Prepaid
Health-Care Setting. 67
Cost-Effective
Treatment for Diabetic End-Stage Renal Disease: Dialysis, Kidney, or Kidney-Pancreas
Transplantation? 94
Cost-Effectiveness
Analyses of the Conversion of Patients With Non-Insulin-Dependent Diabetes
Mellitus from Glipizide to Glyburide and of the Accompanying Pharmacy
Follow-up Clinic. 24
Cost-Effectiveness
Modeling of Simultaneous Pancreas-Kidney Transplantation. 95
Cost-Effectiveness
of Alternative Methods for Retinopathy Screening. 68,
69
Cost-Effectiveness
of Current Approaches to the Control of Retinopathy in Type I Diabetics.
70
Cost-Effectiveness
of Detecting and Treating Retinopathy. 71
Cost-Effectiveness
of Diabetes Education. 265
Cost-Effectiveness
of Early Digit Amputation in the Patient With Diabetes. 108
Cost-Effectiveness
of Medical Nutrition Therapy Provided by Dietitians for Persons with Non-Insulin-
Dependent Diabetes Mellitus. 48
The Cost-Effectiveness
of Preventive Care for Diabetes Mellitus. 266
Cost-Effectiveness
of Screening and Early Treatment of Nephropathy in Patients with Insulin-Dependent
Diabetes Mellitus. 96
Cost-Effectiveness
of Strategies for Detecting Retinopathy. 72
Cost-Effectiveness
of the Screening and Treatment of Retinopathy. What Are the Costs of Underutilization?
73
Cost-Effectiveness
Study of a Lipid-Lowering Therapy in Hyperlipoproteinaemia Type IIb and
Type IV (Frederickson). 25
Cost Efficacy
of Routine Screening for Diabetes in Pregnancy: 1-h Versus 2-h Specimen.
123
The Cost
of Diabetes. 193
Cost of Diabetes
Care. 264
Cost of Diabetes
in France. 194
The Cost
of Diabetic Foot Problems. 196
The Cost
of Diabetic Neuropathy. 197
The Cost
of Education (Editorial). 198
The Cost
of Hospitalization for the Late Complications of Diabetes in the United
States. 143
The Cost
of Immunosuppression and Coverage of Immunosuppressive Drugs for Kidney
Transplant Recipients Under the Medicare Catastrophic Coverage Act. 93
The Cost
of Insulin-Dependent Diabetes Mellitus (IDDM) in England and Wales. 199
Cost of Non-Insulin-Dependent
Diabetes in Women with a History of Gestational Diabetes: Implications
for Prevention. 124
The Cost
of Obesity: The US Perspective. 200
Cost Savings
Associated with Detection and Treatment of Diabetic Eye Disease. 65
The Costs
And Effects of Two Different Lipid Intervention Programmes in Primary
Health Care. 26
The Costs
of Diabetes and Its Complications. 267
Costs of
Diabetes in Texas, 1992. 195
The Costs
of Diabetes-Related Lower Extremity Amputations in the Netherlands. 144
Costs of
Insulin-Dependent Diabetes Mellitus. 201
The Costs
of Nephropathy in Type II Diabetes. 97
Costs of
Temporary and Permanent Disability Induced by Diabetes. 202
Counting
the Cost of Diabetic Hospital Admissions From a Multi-Ethnic Population
in Trinidad. 145
Coverage
of Diabetes Education Programs. 231
D
Detecting
and Treating Retinopathy in Patients with Type I Diabetes Mellitus: A
Health Policy Model. 74
Detecting
and Treating Retinopathy in Patients with Type I Diabetes Mellitus: Savings
Associated with Improved Implementation of Current Guidelines. 75
Detection
of Sight-Threatening Diabetic Eye Disease. 76
The Development
of Community Orientated Recommendations for Diabetes Care in South Auckland.
27
Diabetes.
203
Diabetes
and Long-Term Care. 177
Diabetes
Care in a UK Health Region: Activity, Facilities and Costs. 204
Diabetes
Care in Health Maintenance Organizations. 268
The Diabetes
Education Study: A Controlled Trial of the Effects of Diabetes Patient
Education. 54
Diabetes
Guidelines, Outcomes, and Cost-Effectiveness Study: A Protocol, Prototype,
and Paradigm. 269
Diabetes,
Health Insurance, and Health-Care Reform. 270
Diabetes
in a Managed Care System. 271
Diabetes
in Urban African Americans: III. Management of Type II Diabetes in a Municipal
Hospital Setting. 28
Diabetes
— Inpatient Utilisation, Costs and Data Validity: Dunedin 1985-9.
146
Diabetes
Mellitus and the St. Vincent Declaration: The Economic Implications. 272
Diabetes
Mellitus in Egypt. 205
Diabetes
Outpatient Education: The Evidence of Cost Savings. 232
Diabetes
Patient Education Programs: Quality and Reimbursement. 273
Diabetes-Related
Hospitalization and Hospital Utilization. 147
Diabetes
— The Cost of Illness and the Cost of Control: An Estimate for Sweden
1978. 206
Diabetic
Dyslipidemia: A Case for Aggressive Intervention in the Absence of Clinical
Trial and Cost- effectiveness Data. 274
Diabetic
Foot Care: Financial Implications and Practice Guidelines. 109
Diabetic
Foot Ulcers in a Multidisciplinary Setting: An Economic Analysis of Primary
Healing and Healing With Amputation. 110
Diabetic
Ketoacidosis Charges Relative to Medical Charges of Adult Patients with
Type 1 Diabetes. 178
Diabetic
Ketoacidosis Costs Relative to Medical Costs of Patients with Type 1 Diabetes
[abstract]. 179
Diagnosis
Related Groups, Resource Utilization, Age, and Outcome for Hospitalized
Nephrology Patients. 148
Digging Out
Savings in Diabetes Care: Costing Out Care. 180
Direct and
Indirect Costs of Cardiovascular and Cerebrovascular Complications of
Type II Diabetes. 207
Direct and
Indirect Costs of Diabetes in Minnesota in 1988. 208
Direct and
Indirect Costs of Diabetes in the United States in 1987. 209
Direct and
Indirect Costs of Diabetes in the United States in 1992. 210
Direct Costs
of Diabetes Care: A Survey in Ottawa, Ontario 1986. 160
Drug Consumption
in Elderly Diabetics. 169
E
Economic
Analysis of Captopril in the Treatment of Diabetic Nephropathy. 98
Economic
Consequences of Diabetes Mellitus in the U.S. in 1997. 211
Economic
Cost of Diabetes Mellitus: Minnesota, 1988. 212
The Economic
Cost of Obesity: The French Situation. 213
Economic
Costs of Diabetes. 275
The Economic
Costs of Non-Insulin-Dependent Diabetes Mellitus. 214
Economic
Costs of Obesity. 215
The Economic
Costs of NIDDM. 276
Economic
Evaluation of the Contribution of Captopril in the Treatment of Diabetic
Nephropathy: A Cost- Effectiveness Approach. 99
Economic
Evaluations of Type II Diabetes. 216
Economic
Impact of Diabetes. 217, 218
Economic
Impact of Diabetes Mellitus in the Elderly. 181
Economic
Impact of Type II Diabetes Mellitus. 219
Economic
Implications of IGT Intervention: The Case of a "Phantom Alternative"?
277
The Economics
of Pharmacotherapy for Diabetes Mellitus. 170
The Economics
of Screening for Microalbuminuria in Patients with Insulin-Dependent Diabetes
Mellitus. 161 "Educating"
the Person With Diabetes in an Ambulatory Setting. 162
Effect of
Diabetes Education on Self-Care Metabolic Control and Emotional Well-Being.
55, 56
Effect of
Third Party Reimbursement on the Utilization of Services and Indices of
Diabetes Management Among Inner City Diabetic Patients. 182
Effect of
Value-Added Utilities on Prescription Refill Compliance and Medicaid Health
Care Expenditures: A Study of Patients with Non-Insulin-Dependent Diabetes
Mellitus. 29
The Effectiveness
of Diabetes Education for Non-Insulin-Dependent Diabetic Persons. 57
Effectiveness
of Glycosylated Hemoglobin, Fasting Plasma Glucose, and a Single Post
Load Plasma Glucose Level in Population Screening for Glucose Intolerance.
5 Effectiveness of Screening for Diabetes. 1
Effects of
Diet and Exercise Interventions on Control and Quality of Life in Non-Insulin-Dependent
Diabetes. 49
Effects of
Educational Interventions in Diabetes Care: A Meta-Analysis of Findings.
58
Efficacy
of Insulin and Sulfonylurea Combination Therapy in Type II Diabetes. A
Meta-Analysis of the Randomized Placebo-Controlled Trials. 30.Emotional
Side Effects of Diabetes Educational Program (letter; comment). 278
Employment,
Work Disability, and Income Support Program Participation. 100
Estimating
the Impact of Total Illness Burden on Patient Outcomes Among Patients
with Non-Insulin Dependent Diabetes: A Comparison of Three Co-Morbidity
Measures (abstract). 279
Evaluating
the Costs and Benefits of Outpatient Diabetes Education and Nutrition
Counseling. 59
Evaluation
of a Practice-Based Programme of Health Checks: Financial Cost and Success
at Risk Detection. 31
Evaluation
of a Structured Treatment and Teaching Program for Non-Insulin-Treated
Type II Diabetic Outpatients in Germany After the Nationwide Introduction
of Reimbursement Policy for Physicians. 60
Evaluation
of Argon Laser Treatment of Retinopathy and Its Diffusion in The Netherlands.
77
The Evaluation
of Mobile Screening for Retinopathy. 78
Evaluation
of the Costs to Medicare of Covering Therapeutic Shoes for Diabetic Patients.
111
Evaluative
Approaches to Type II Diabetes. 233
F
The Feasibility
of a Potentially "Ideal" System of Integrated Diabetes Care
and Education Based on a Day Centre. 32
Financial
Implications of Implementing Standards of Care for Diabetes and Pregnancy.
136
Financial
Implications of Implementing Standards of Care for Diabetic Eye Disease.
280
Financing
the Care of Diabetes Mellitus in the U.S.: Background, Problems, and Challenges.
220
First Prenatal
Visit Glucose Screening. 127
The First
Two Years of Type I Diabetes in Children: Length of the Initial Hospital
Stay Affects Costs but Not Effectiveness of Care. 149
Foot Infections
in Diabetic Patients: Decision and Cost-Effectiveness Analyses. 112
Fructosamine
or Glycated Haemoglobin as a Measure of Diabetic Control? 33
G
The Glycosylated
Hemoglobin as a Diagnostic and Monitoring Tool for Diabetes: Evidence
from Claims Data (abstract). 6
H
The Health
Belief Model and Adolescents with Insulin-Dependent Diabetes Mellitus.
281
Health Care
Expenditures for People with Diabetes Mellitus, 1992. 183
Health Insurance
and the Financial Impact of IDDM in Families with a Child with IDDM. 163
Health-Insurance
Coverage for Adults with Diabetes in the U.S. Population. 282
Hospital
Charges. 101
Hospital
Costs, Use of Resources, and Dynamics of Death Associated with Diabetes
Mellitus. 164
Hospitalization
and Expenditures for the Treatment of General Medical Conditions Among
the U.S. Diabetic Population in 1991. 150
Hospitals
Adopt Intensive Programs for Diabetic Patients to Avoid High Inpatient
Costs. 151
Hypoglycemic
Drugs in the Treatment of Non Insulin Dependent Diabetes Mellitus (NIDDM)
in Klong Toey Slum (abstract). 171
I
Immunization
to Prevent Insulin-dependent Diabetes Mellitus? The Economics of Genetic
Screening and Vaccination for Diabetes. 7
Importance
of Outpatient Supervision in the Prognosis of Juvenile Diabetes Mellitus:
A Cost/Benefit Analysis. 34
Improving
the Financing of Diabetes Care in the 1990's: Recommendations of the 1989
Conference. 234
The Indirect
Costs of Morbidity in Type II Diabetic Patients. 221
Inpatient
or Outpatient Initiation of Insulin Therapy: Experience and Cost Effective
Analysis in a Suboptimal Clinical Setting. 35
Insulin-Glyburide
Combination Therapy for Non-Insulin-Dependent Diabetes Mellitus: A Long-Term
Double- Blind, Placebo-Controlled Trial. 37
Insulin Injection
Technique Can Be Taught Without Hospitalization. 36
Insurance
Coverage for People with Diabetes: Third party Reimbursement for Diabetes
Education and Technologies. 283
Intensive
Ambulatory Treatment of Insulin-Dependent Diabetes. 284
Intensive
Insulin Therapy: Part I. Basic Principles. 285
Intensive
Insulin Therapy: Part II. Multicomponent Insulin Regimens. 286
Is Glycohemoglobin
Testing Useful in Diabetes Mellitus? Lessons from the Diabetes Control
and Complications Trial. 287
Is Screening
and Intervention for Microalbuminuria Worthwhile in Patients With Insulin
Dependent Diabetes? 102
L
Labour Productivity
Effects of Prescribed Medicines for Chronically Ill Workers. 172
Less Expensive,
Reliable Blood Glucose Self-Monitoring. 38
Lifetime
Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control
and Complications Trial. 39
Local Survey
of Optometrists about Dilated Funduscopic Examinations for Patients with
Diabetes: Making Use of Phone Book Yellow-Page Listings. 79
Long-Term
Costs for Foot Ulcers in Diabetic Patients in a Multidisciplinary Setting.
113
M
Managed Care
Approaches to Diabetes Mellitus. 288
Management
of Patients with Diabetes by Nurses with Support of Subspecialists. 40
Medical and
Financial Implications of Discontinuing a Statewide Free Insulin Program
Involving 3,720 People. 165
Medical Expenditures
and Insurance Coverage for People with Diabetes: Estimates from the National
Medical Care Expenditure Survey. 184
Medical Technology
and Costs of the Medicare Program. 235
Medicare
Admission Criteria for Diabetes Mellitus in Florida. 289
Medicare
Supplement Plan Required to Cover Diabetes. 228
Medicare
Therapeutic Shoe Demonstration: Report to Congress. 114
Medicare
Therapeutic Shoes Demonstration: Was the Demonstration Cost Effective?
Final Comprehensive Report, Volume I. 115
Medication
Cost Savings Associated with Weight Loss for Obese Non-Insulin-Dependent
Diabetic Men and Women. 173
Meeting the
Challenge of Diabetic Blindness in the 90's. 80
Meeting the
Needs of the Economically Deprived Diabetic. 290
Mobile Retinal
Photography: A Means of Screening for Retinopathy in Aboriginal Communities.
81
Money Matters:
Should Ability to Pay Ever Be a Consideration in Gaining Access to Transplantation?
291
Multiple
Biochemical Blood Testing as a Case-Finding Tool in Ambulatory Medical
Patients. 8
Must Diabetes
Be a Fatal Disease in Africa? Study of Costs of Treatment. 185
N
The National
Long-Range Plan to Combat Diabetes, 1987. 236
National
Standards and Review Criteria for Diabetes Patient Education Programs:
Quality Assurance for Diabetes Patient Education. 237
New Approaches
to Medical Technology Coverage: Conference Proceedings. 238
New Mexicare.
292
Nurses' Perceptions:
Issues that Arise in Caring for Patients with Diabetes in a Managed Care
Environment (abstract). 293
Nursing Case
Management: An Innovative Model of Care for Hospitalized Patients with
Diabetes. 41
O
Obesity and
the U.S. Navy [letter]. 61
Office Visits
for Diabetes Mellitus: United States, 1989. 239
Operations,
Total Hospital Stay and Costs of Critical Leg Ischemia. A Population-Based
Longitudinal Outcome Study of 321 Patients. 152
Ophthalmic
Screening for Diabetics: The Importance of Physician-Ophthalmologist Collaboration
in the Prevention of Blindness. 82
Opportunities
for Cost Reduction in Retinopathy Treatment: Case Study From Mexico. 83
Optometrist Screening for Retinopathy: Evidence and Environment. 294
Oral Hypoglycemic
Agents in the Treatment of Type II Diabetes. 174
Osteomyelitis
in Feet of Diabetics: Clinical Accuracy, Surgical Utility, and Cost-Effectiveness
of MR Imaging. 116
An Outpatient-Focused
Program for Childhood Diabetes: Design, Implementation, and Effectiveness.
166
P
Pancreas
Transplantation as a Treatment for Diabetes: Indications and Outcome.
103
Pancreas
Transplantation for Type I Diabetes Mellitus: Do the Benefits Offset the
Risks and Cost? 295
Patient Education
Financing Under Medicare. 296
Patterns
of Hospitalization in a Pediatric Diabetes Clinic in Sydney. 153
Paying for
Preventive Care: Moving the Debate Forward. 297
Payment for
Diabetes Care Under the Medicare Fee Schedule. 298
Perceived
Effectiveness, Cost, and Availability of Patient Education Methods and
Materials. 299
Pointers
to Preventing Hyperglycaemic Emergencies in Soweto. 42
Population-based
Screening for Retinopathy: A Promising Start (Comment). 84
Potential
for Reducing Health Care Costs by Public and Patient Education: Summary
of Selected Studies. 300
Practical
Community Screening for Retinopathy Using the Mobile Retinal Camera: Report
of a 12 Centre Study. 84
Practice
Guidelines for Nutrition Care by Dietetics Practitioners for Outpatients
with Non-Insulin-Dependent Diabetes Mellitus: Consensus Statement. 240
Practice
Guidelines for Nutrition Care by Dietetics Practitioners for Outpatients
with Non-Insulin-Dependent Diabetes Mellitus: Methodologies for Field
Testing and Cost-Effectiveness Analysis. 241
Precipitants
of Hospitalization in Insulin-Dependent Diabetes Mellitus (IDDM): A Statewide
Perspective. 154
Precision
and Costs of Techniques for Self-Monitoring of Serum Glucose Levels. 43
Preventing
Diabetic Foot Disease: Lessons From the Medicare Therapeutic Shoe Demonstration.
117
Prevention:
The Cost-Effectiveness of the California Diabetes and Pregnancy Program.
137
Preventive
Eye Care in People with Diabetes Is Cost-Saving to the Federal Government:
Implications for Health Care Reform. 85
Preventive
Health Services for Medicare Beneficiaries: Policy and Research Issues.
242
Preventive
Services. 243
Profiling
Overweight Patients in the U.S. Navy: Health Conditions and Costs. 222
A Prospective
Evaluation of Transcutaneous Oxygen Measurements in the Management of
Diabetic Foot Problems. 118
Prospective
Reimbursement and Diabetes Mellitus: Impact Upon Glycemic Control and
Utilization of Health Services. 186
Psychosocial
Challenges for Children with Insulin-Dependent Diabetes Mellitus. 301
Public Cost
and Access to Primary Care for Hyperglycemic Emergencies, Clark County,
Nevada. 155
Public Health
Focus: Physical Activity and the Prevention of Coronary Heart Disease.
244
Public Health
Focus: Prevention of Blindness Associated with Retinopathy. 245
Q
Quality Assurance
Issues. 302
Quality-of-Life
Evaluation in Diabetes. 303
R
Randomized
Controlled Multicentre Evaluation of an Education Programme for Insulin-Treated
Diabetic Patients: Effects on Metabolic Control, Quality of Life, and
Costs of Therapy. 44
A Randomized
Study of the Effects of a Home Diabetes Education Program. 62
Rationale
for the Hypertension Guidelines for Primary Care in South Africa. 304
A RCT of
Community Clinic Versus Hospital Outpatient Care in the Treatment of Non
Insulin Dependent Diabetes Mellitus (NIDDM): Abstract. 187
Rediagnosing
Health Care: Providers' Perspectives. 246
Reduced Hospital
Utilization and Cost Savings Associated with Diabetes Patient Education.
63
Reimbursement
for Diabetes Self-Care Training: The North Carolina Experience. 305
Reimbursement
Issues in Diabetes. 306
Reins or
Fences: A Physician's View of Cost Containment. 307
A Relative
Cost-Effectiveness Analysis of Different Methods of Screening for Retinopathy.
86
Relative
Risk and Economic Consequences of Inpatient Care Among Patients With Renal
Failure. 156
Relevance
of Postprandial Glycosuria in Survey for Diabetes Mellitus. 308
Reliability
and Cost of Diabetic Diets. 50
Resource
Manual to Help Your Program Meet the National Standards. 247
Resource
Utilization and Costs of Care in the Diabetes Control and Complications
Trial. 167
Resource
Utilization in Treatment of Diabetic Ketoacidosis in Adults. 157
Retinopathy
in the West of Scotland: Its Detection and Prevalence, and the Cost-Effectiveness
of a Proposed Screening Programme. 87
Retinopathy
— Need and Demand for Photocoagulation and Its Cost-Effectiveness:
Evaluation Based on Services in the United Kingdom. 88
A Risk-Benefit
Assessment of Conventional Versus Intensive Insulin Therapy. 45
S
Scientific
Rigor of Economic Analyses (letter). 309
Screening
for Diabetes Mellitus. 248
Screening
for Diabetes Mellitus in General Practice Using a Reflectance Meter System:
The Islington Diabetes Survey. 9
Screening
for Gestational Diabetes. 128
Screening
for Gestational Diabetes: An Analysis of Health Benefits and Costs. 130
Screening
for Gestational Diabetes: Analysis by Screening Criteria. 129
Screening
for Gestational Diabetes in a High-Risk Population. 131
Screening
for Retinopathy. 310
Screening
for Retinopathy: A Relative Cost-Effectiveness Analysis of Alternative
Modalities and Strategies. 10
Screening
for Retinopathy in a Clinical Setting: A Comparison of Direct Ophthalmoscopy
by Primary Care Physicians with Fundus Photography. 89
Screening
for Retinopathy in South Africa with 60° Retinal Colour Photography. 90
Screening
of High-Risk and General Populations for Gestational Diabetes: Clinical
Application and Cost Analysis. 132
Should Persons
with Diabetes Be Licensed to Drive Trucks? Risk Management. 311
A Simple
Economic Evaluation Model for Selecting Diabetes Health Care Strategies.
188
Simultaneous
Pancreas-Kidney Transplantation (SPK): A Cost-Effectiveness Analysis Model
(abstract). 104
Social and
Economic Costs of Diabetes: An Estimate for 1979. 223
Social and
Economic Impact on Youth-Onset Diabetes in Japan. 312
The Socio-Economic
Cost of Diabetic Complications in France. 224
Source Book
of Health Insurance Data 1991. 249
Spin-off
Cost/Benefits of Expanded Nutritional Care. 51
Statistics,
CPT, ICD-9, CDM, and Level III Codes: What Are They and How Did I Get
This Job? 313
Structure
and Costs of Health Care of Diabetic Patients in Finland. 225
Summary Document
of Nutrition Intervention in Diabetes. 314
Systematic
Care of Diabetic Patients in One General Practice: How Much Does It Cost?
226
T
Tallying
the Cost Of Diabetes. 189
Targeted
Screening for Diabetes in Community Chiropody Clinics. 11
Technical
and Clinical Evaluation of Fructosamine Determination in Serum. 2
Therapeutic
Interventions in the Progression of Diabetic Nephropathy. 105
Third Party
Coverage for Diabetes Education Program. 250
Third Party
Reimbursement for Diabetes Mellitus: Outpatient Education: A Year's Progress.
64
Third Party
Reimbursement for Outpatient Diabetes Education and Counseling. 251
Towards Less
Amputations in Diabetic Patients: Incidence, Causes, Cost, Treatment,
and Prevention — A Review. 119
Trends in
Medicare Reimbursement for End-Stage Renal Disease: 1974-1979. 190
Type I Diabetic
Nephropathy: Clinical Characteristics and Economic Impact. 106
U
Use of Health
Maintenance Organization Data Bases To Study Pharmacy Resource Usage in
Diabetes Mellitus. 175
Use of Mobile
Screening Unit for Retinopathy in Rural and Urban Areas. 91
Utility of
Serum Fructosamine as a Measure of Glycemia in Young and Old Diabetic
and Non-Diabetic Subjects. 46
V
Value of
Serum Glucose Assay as Part of the Biochemical Profile in Screening for
Diabetes. 12
Variation
in Office-Based Quality: A Claims-Based Profile of Care Provided to Medicare
Patients with Diabetes. 47
W
Weight Excess
Before Pregnancy: Complications and Cost. 133
Where Do
We Go From Here? 315
Where Have
All the Pennies Gone? The Work of Manchester Medical Audit Advisory Group.
316
Why Do Elderly
Diabetics Burden the Health Care System More Than Non-Diabetics? 191
Women with
Diabetes During Pregnancy: Sociodemographics, Outcomes, and Costs of Care.
138
Worksheet
to Estimate Program Costs and Savings. 252
Back
to Economics of Diabetes Mellitus Indexes
Top of page
Historical
Page last modified: December 20, 2005
Content Source: National Center for Chronic Disease Prevention and Health Promotion
Division of Diabetes Translation
|
Diabetes & Me